EQHQ
Login
EQHQ
Search your stocks
Login
Command Palette
Search for a command to run...
Explore
Watchlists
Chat
Portfolio
Share
Profile
AJANTPHARM
Overview
Shareholding
Peers
Financials
Ratios
Concall
Feed
Documents
AJANTPHARM
Ajanta Pharma Ltd.
2545.8
(-0.10%)
1W: -0.50%
1M: -3.32%
1Y: +13.84%
Ratios
Cash Conversion Cycle
Latest:
-93.4 days
Return on Equity
Latest:
23.5%
Return on Capital Employed
Latest:
32.2%
Dupont Analysis
Analysis Summary
Metric
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
ROE
19.32%
23.38%
22.77%
17.68%
23.49%
PAT margin
19.39%
15.71%
21.33%
22.63%
18.07%
Asset Turnover
0.80x
0.77x
0.82x
1.61x
1.73x
Leverage
1.34x
1.37x
1.33x
1.34x
1.33x
Efficiency Ratios
Analysis Summary
Metric
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Inventory Days
65.7
78.1
83.7
40.9
37.6
Receivable Days
87.1
93.7
94.5
52.9
52.7
Payable Days
199.4
260.9
188.8
157.4
183.7
Cash Conversion Cycle
-46.6
-89.1
-10.6
-63.7
-93.4
Return Ratios
Analysis Summary
Metric
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
ROE
19.32%
23.38%
22.77%
17.68%
23.49%
ROCE
27.44%
32.20%
29.37%
22.57%
32.22%
ROA
14.44%
17.03%
17.16%
13.21%
17.73%
Explore
Watchlists
Chat
Portfolio